Kamada Ltd (KMDA) SEC Filing 6-K Foreign Issuer Report for the period ending Wednesday, July 6, 2022

Kamada Ltd

CIK: 1567529 Ticker: KMDA

View differences made from one to another to evaluate Kamada Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Kamada Ltd.


Assess how Kamada Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Kamada Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Kamada Ltd provided additional information to their SEC Filing as exhibits

Ticker: KMDA
CIK: 1567529
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001213900-22-037421
Submitted to the SEC: Wed Jul 06 2022 6:01:13 AM EST
Accepted by the SEC: Wed Jul 06 2022
Period: Wednesday, July 6, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: